GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Solanbridge Group SLNX · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

About Solanbridge Group

Its shares trade under the ticker SLNX. It has been listed since 29 June 2007. In the fiscal year to 31 December 2014, it reported revenue of $229,072 and a net loss of $2,149. At that date it held total assets of $53,320 and shareholders' equity of −$203,484.

Solanbridge Group Inc. is a biotechnology company, which engages in the research, development, and production of nutraceutical and cosmetic products. The company is headquartered in Spring, Texas. The company went IPO on 2007-06-29. The firm is a holding company. The firm is looking to expand into the medical marijuana industry by developing a commercial grower's license in the Province of Nova Scotia, Canada and developing cannbidiol (CBD) infused products in Nevada, California and Colorado. The firm focuses on providing a product that will help physicians and patients in managing health, and it will be available only to Canadians holding a legal license to possess medical marijuana. Solanbridge Group Nova Scotia, Inc. is a subsidiary of the Company.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
N/A
Industry
N/A
Listed since
29 Jun 2007

Leadership

Pay as last reported

  • Charles ShirleyChief Executive Officer, Director, since 2011
  • Joseph CurciDirector
  • Earle HickeyDirector
  • Rosalia MirayDirector
  • Luis MoraDirector

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Solanbridge Group Inc possesses several key strengths which contribute to its success in the market:

Weaknesses

  • Despite its strengths, Solanbridge Group Inc also faces certain weaknesses that need to be addressed:

Opportunities

  • Solanbridge Group Inc can capitalize on the following opportunities to further enhance its market position:

Threats

  • Solanbridge Group Inc should be aware of the following threats that could impact its business:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.